AMN Healthcare Services, Inc.
US ˙ NYSE ˙ US0017441017

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Mark G Foletta. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Mark G Foletta har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:DXCM / DexCom, Inc. Director 51.121
US:AMN / AMN Healthcare Services, Inc. Director 13.273
US:ENTA / Enanta Pharmaceuticals, Inc. Director 7.500
US:TOCA / Tocagen Inc. EVP & Chief Financial Officer 30.000
US:RGLS / Regulus Therapeutics Inc. Director 81.910
US:BIOC / Biocept Inc Interim CFO 50.000
Director 0
US:AMLN / Amylin Pharmaceuticals Inc SVP, Chief Financial Officer 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Mark G Foletta. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb AMN / AMN Healthcare Services, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AMN / AMN Healthcare Services, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2024-02-29 AMN FOLETTA MARK G 500 56,9000 500 56,9000 28.450 152 68.0500 5.575 19,60

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AMN / AMN Healthcare Services, Inc. Insider Trades
Insidersalg AMN / AMN Healthcare Services, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AMN / AMN Healthcare Services, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2021-06-11 AMN FOLETTA MARK G 2.500 95,0160 2.500 95,0160 237.540 336 85.0700 -24.865 -10,47
2017-11-27 AMN FOLETTA MARK G 2.500 47,0300 2.500 47,0300 117.575
2017-06-13 AMN FOLETTA MARK G 1.500 36,7050 1.500 36,7050 55.058
2016-12-15 AMN FOLETTA MARK G 1.800 37,8100 1.800 37,8100 68.058

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AMN / AMN Healthcare Services, Inc. Insider Trades
Insiderkøb ENTA / Enanta Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AMN / AMN Healthcare Services, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ENTA / Enanta Pharmaceuticals, Inc. Insider Trades
Insidersalg ENTA / Enanta Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AMN / AMN Healthcare Services, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ENTA / Enanta Pharmaceuticals, Inc. Insider Trades
Insiderkøb FBRX / Forte Biosciences, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AMN / AMN Healthcare Services, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2019-05-28 TOCA FOLETTA MARK G 5.000 4,2950 5.000 4,2950 21.475 31 6.6800 11.925 55,53
2017-04-19 TOCA FOLETTA MARK G 5.000 10,0000 5.000 10,0000 50.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FBRX / Forte Biosciences, Inc. Insider Trades
Insidersalg FBRX / Forte Biosciences, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AMN / AMN Healthcare Services, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FBRX / Forte Biosciences, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Mark G Foletta som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-08-18 2025-08-15 4 DXCM DEXCOM INC
Common Stock
S - Sale -195 51.121 -0,38 81,54 -15.900 4.168.406
2025-08-18 2025-08-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -2.555 51.316 -4,74 81,02 -207.003 4.157.550
2025-07-17 2025-07-15 4 DXCM DEXCOM INC
Common Stock
S - Sale -8 53.871 -0,01 86,03 -688 4.634.522
2025-07-17 2025-07-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -2.742 53.879 -4,84 85,17 -233.528 4.588.724
2025-06-18 2025-06-16 4 DXCM DEXCOM INC
Common Stock
S - Sale X -2.750 56.621 -4,63 83,13 -228.605 4.706.847
2025-05-12 2025-05-08 4 DXCM DEXCOM INC
Common Stock
A - Award 5.731 5.731
2025-05-12 2025-05-08 4 DXCM DEXCOM INC
Common Stock
G - Gift 2.973 59.371 5,27
2025-05-12 2025-05-08 4 DXCM DEXCOM INC
Common Stock
G - Gift -2.973 0 -100,00
2025-04-21 2025-04-19 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
M - Exercise 3.019 13.273 29,44
2024-06-20 2024-06-18 4 DXCM DEXCOM INC
Common Stock
S - Sale X -299 56.398 -0,53 117,25 -35.056 6.612.412
2024-06-20 2024-06-18 4 DXCM DEXCOM INC
Common Stock
S - Sale X -3.007 56.697 -5,04 116,75 -351.065 6.619.335
2024-06-20 2024-06-17 4 DXCM DEXCOM INC
Common Stock
S - Sale X -475 59.704 -0,79 117,77 -55.942 7.031.442
2024-06-20 2024-06-17 4 DXCM DEXCOM INC
Common Stock
S - Sale X -2.212 60.179 -3,55 117,16 -259.159 7.050.614
2024-06-20 2024-06-17 4 DXCM DEXCOM INC
Common Stock
S - Sale X -7 62.391 -0,01 115,18 -806 7.186.195
2024-05-24 2024-05-22 4 DXCM DEXCOM INC
Common Stock
A - Award 2.973 2.973
2024-05-21 2024-05-18 4 DXCM DEXCOM INC
Common Stock
G - Gift 3.306 62.398 5,59
2024-05-21 2024-05-18 4 DXCM DEXCOM INC
Common Stock
G - Gift -3.306 0 -100,00
2024-04-23 2024-04-19 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
M - Exercise 1.681 10.254 19,61
2024-03-01 2024-02-29 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
P - Purchase 500 8.573 6,19 56,90 28.450 487.804
2023-05-22 2023-05-18 4 DXCM DEXCOM INC
Common Stock
G - Gift 4.488 59.092 8,22
2023-05-22 2023-05-18 4 DXCM DEXCOM INC
Common Stock
G - Gift -4.488 3.306 -57,58
2023-05-22 2023-05-18 4 DXCM DEXCOM INC
Common Stock
A - Award 3.306 7.794 73,66 0,00 3 8
2023-04-25 2023-04-21 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
S - Sale X -1.458 8.073 -15,30 88,78 -129.441 716.721
2023-04-25 2023-04-21 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
M - Exercise 1.458 9.531 18,06
2023-04-13 2023-04-11 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
S - Sale X -1.053 8.073 -11,54 84,63 -89.115 683.218
2023-04-13 2023-04-11 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
S - Sale X -4.989 9.126 -35,35 84,29 -420.523 769.231
2022-12-16 2022-11-15 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
G - Gift -300 14.115 -2,08
2022-05-23 2022-05-20 4 DXCM DEXCOM INC
Common Stock
A - Award 1.122 1.122 0,00 1 1
2022-05-23 2022-05-19 4 DXCM DEXCOM INC
Common Stock
J - Other 1.054 13.651 8,37
2022-05-23 2022-05-19 4 DXCM DEXCOM INC
Common Stock
J - Other -1.054 0 -100,00
2022-04-22 2022-04-21 4 AMN AMN HEALTHCARE SERVICES INC
Restricted Stock Units
A - Award 1.458 1.458
2022-04-22 2022-04-21 4 AMN AMN HEALTHCARE SERVICES INC
Restricted Stock Units
M - Exercise -2.139 0 -100,00
2022-04-22 2022-04-21 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
M - Exercise 2.139 14.415 17,42
2022-03-07 2022-03-03 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 7.500 7.500
2021-12-02 2021-12-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -41 12.597 -0,32 569,54 -23.351 7.174.475
2021-12-02 2021-12-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -2 12.638 -0,02 567,35 -1.135 7.170.201
2021-12-02 2021-12-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -87 12.640 -0,68 565,51 -49.200 7.148.082
2021-12-02 2021-12-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -65 12.727 -0,51 564,24 -36.675 7.181.054
2021-12-02 2021-12-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -116 12.792 -0,90 562,79 -65.283 7.199.188
2021-12-02 2021-12-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -78 12.908 -0,60 561,85 -43.824 7.252.369
2021-12-02 2021-12-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -70 12.986 -0,54 558,78 -39.115 7.256.325
2021-12-02 2021-12-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -41 13.056 -0,31 556,89 -22.832 7.270.756
2021-11-02 2021-11-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -40 13.097 -0,30 634,01 -25.360 8.303.629
2021-11-02 2021-11-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -40 13.137 -0,30 631,26 -25.250 8.292.863
2021-11-02 2021-11-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -42 13.177 -0,32 629,33 -26.432 8.292.681
2021-11-02 2021-11-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -76 13.219 -0,57 628,41 -47.759 8.306.917
2021-11-02 2021-11-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -56 13.295 -0,42 627,79 -35.156 8.346.529
2021-11-02 2021-11-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -7 13.351 -0,05 626,04 -4.382 8.358.327
2021-11-02 2021-11-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -124 13.358 -0,92 625,32 -77.540 8.353.007
2021-11-02 2021-11-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -43 13.482 -0,32 624,10 -26.836 8.414.076
2021-11-02 2021-11-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -13 13.525 -0,10 622,62 -8.094 8.421.003
2021-11-02 2021-11-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -14 13.538 -0,10 619,32 -8.670 8.384.354
2021-11-02 2021-11-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -45 13.552 -0,33 615,13 -27.681 8.336.242
2021-10-05 2021-10-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -1 13.597 -0,01 551,58 -552 7.499.833
2021-10-05 2021-10-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -51 13.598 -0,37 547,06 -27.900 7.438.906
2021-10-05 2021-10-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -181 13.649 -1,31 544,39 -98.535 7.430.420
2021-10-05 2021-10-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -126 13.830 -0,90 543,15 -68.437 7.511.733
2021-10-05 2021-10-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -88 13.956 -0,63 540,93 -47.602 7.549.219
2021-10-05 2021-10-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -6 14.044 -0,04 539,10 -3.235 7.571.120
2021-10-05 2021-10-01 4 DXCM DEXCOM INC
Common Stock
S - Sale X -47 14.050 -0,33 538,02 -25.287 7.559.181
2021-06-15 2021-06-11 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
S - Sale -2.500 12.276 -16,92 95,02 -237.540 1.166.416
2021-05-25 2021-05-21 4 DXCM DEXCOM INC
Common Stock
A - Award 1.054 1.054 0,00 1 1
2021-05-25 2021-05-20 4 DXCM DEXCOM INC
Common Stock
J - Other 895 14.097 6,78
2021-05-25 2021-05-20 4 DXCM DEXCOM INC
Common Stock
J - Other -895 0 -100,00
2021-04-23 2021-04-21 4 AMN AMN HEALTHCARE SERVICES INC
Restricted Stock Units
A - Award 2.139 2.139
2021-04-23 2021-04-21 4 AMN AMN HEALTHCARE SERVICES INC
Restricted Stock Units
M - Exercise -2.826 0 -100,00
2021-04-23 2021-04-21 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
M - Exercise 2.826 14.776 23,65
2021-03-04 2021-03-02 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 7.500 7.500
2020-11-18 2020-11-16 4 DXCM DEXCOM INC
Common Stock
S - Sale X -301 13.202 -2,23 342,93 -103.222 4.527.349
2020-11-18 2020-11-16 4 DXCM DEXCOM INC
Common Stock
S - Sale X -428 13.503 -3,07 341,79 -146.284 4.615.136
2020-11-18 2020-11-16 4 DXCM DEXCOM INC
Common Stock
S - Sale X -117 13.931 -0,83 340,23 -39.807 4.739.798
2020-11-18 2020-11-16 4 DXCM DEXCOM INC
Common Stock
S - Sale X -139 14.048 -0,98 337,78 -46.951 4.745.133
2020-11-18 2020-11-16 4 DXCM DEXCOM INC
Common Stock
S - Sale X -15 14.187 -0,11 336,98 -5.055 4.780.745
2020-10-19 2020-10-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -208 14.202 -1,44 398,25 -82.835 5.655.907
2020-10-19 2020-10-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -375 14.410 -2,54 397,41 -149.030 5.726.730
2020-10-19 2020-10-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -255 14.785 -1,70 396,51 -101.109 5.862.349
2020-10-19 2020-10-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -120 15.040 -0,79 395,02 -47.402 5.941.101
2020-10-19 2020-10-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -42 15.160 -0,28 391,48 -16.442 5.934.902
2020-09-16 2020-09-14 4 DXCM DEXCOM INC
Common Stock
S - Sale X -114 15.202 -0,74 397,75 -45.344 6.046.623
2020-09-16 2020-09-14 4 DXCM DEXCOM INC
Common Stock
S - Sale X -121 15.316 -0,78 396,17 -47.936 6.067.692
2020-09-16 2020-09-14 4 DXCM DEXCOM INC
Common Stock
S - Sale X -222 15.437 -1,42 395,28 -87.753 6.101.970
2020-09-16 2020-09-14 4 DXCM DEXCOM INC
Common Stock
S - Sale X -231 15.659 -1,45 393,73 -90.951 6.165.388
2020-09-16 2020-09-14 4 DXCM DEXCOM INC
Common Stock
S - Sale X -200 15.890 -1,24 391,95 -78.390 6.228.060
2020-09-16 2020-09-14 4 DXCM DEXCOM INC
Common Stock
S - Sale X -109 16.090 -0,67 390,86 -42.604 6.288.905
2020-09-16 2020-09-14 4 DXCM DEXCOM INC
Common Stock
S - Sale X -3 16.199 -0,02 386,21 -1.159 6.256.216
2020-07-01 2020-06-29 4 ENTA ENANTA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 17.000 17.000
2020-05-27 2020-05-22 4 DXCM DEXCOM INC
Common Stock
A - Award 895 895 0,00 1 1
2020-05-27 2020-05-21 4 DXCM DEXCOM INC
Common Stock
J - Other 3.055 16.202 23,24
2020-05-27 2020-05-21 4 DXCM DEXCOM INC
Common Stock
J - Other -3.055 0 -100,00
2020-04-24 2020-04-22 4 AMN AMN HEALTHCARE SERVICES INC
Restricted Stock Units
A - Award 2.826 2.826
2020-04-21 2020-04-17 4 AMN AMN HEALTHCARE SERVICES INC
Restricted Stock Units
M - Exercise -2.907 0 -100,00
2020-04-21 2020-04-17 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
M - Exercise 2.907 11.950 32,15
2020-03-04 2020-03-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -84 13.147 -0,63 288,26 -24.214 3.789.754
2020-03-04 2020-03-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -75 13.231 -0,56 285,48 -21.411 3.777.196
2020-03-04 2020-03-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -84 13.306 -0,63 282,77 -23.753 3.762.538
2020-03-04 2020-03-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -53 13.390 -0,39 281,60 -14.925 3.770.691
2020-03-04 2020-03-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -31 13.443 -0,23 279,60 -8.668 3.758.649
2020-03-04 2020-03-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -64 13.474 -0,47 277,48 -17.759 3.738.784
2020-03-04 2020-03-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -114 13.538 -0,84 275,56 -31.414 3.730.546
2020-03-04 2020-03-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -155 13.652 -1,12 274,88 -42.607 3.752.708
2020-03-04 2020-03-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -81 13.807 -0,58 272,82 -22.098 3.766.826
2020-03-04 2020-03-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -152 13.888 -1,08 271,54 -41.274 3.771.138
2020-03-04 2020-03-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -107 14.040 -0,76 270,63 -28.957 3.799.592
2020-02-05 2020-02-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -9 14.147 -0,06 240,68 -2.166 3.404.853
2020-02-05 2020-02-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -166 14.156 -1,16 238,86 -39.650 3.381.251
2020-02-05 2020-02-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -524 14.322 -3,53 238,05 -124.736 3.409.305
2020-02-05 2020-02-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -301 14.846 -1,99 236,84 -71.290 3.516.196
2020-01-07 2020-01-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -133 15.147 -0,87 218,94 -29.118 3.316.216
2020-01-07 2020-01-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -339 15.280 -2,17 218,39 -74.035 3.337.050
2020-01-07 2020-01-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -528 15.619 -3,27 217,61 -114.899 3.398.882
2019-12-05 2019-12-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -462 16.147 -2,78 228,93 -105.766 3.696.562
2019-12-05 2019-12-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -233 16.609 -1,38 227,66 -53.046 3.781.266
2019-12-05 2019-12-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -232 16.842 -1,36 226,20 -52.478 3.809.664
2019-12-05 2019-12-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -70 17.074 -0,41 223,41 -15.639 3.814.502
2019-12-05 2019-12-03 4 DXCM DEXCOM INC
Common Stock
S - Sale X -3 17.144 -0,02 221,34 -664 3.794.653
2019-10-04 2019-10-04 4 TOCA Tocagen Inc
Employee Stock Option (right to buy)
A - Award 30.000 30.000
2019-06-04 2019-05-31 4 DXCM DEXCOM INC
Common Stock
A - Award 3.055 3.055 0,00 3 3
2019-06-04 2019-05-30 4 DXCM DEXCOM INC
Common Stock
J - Other 4.052 17.147 30,94
2019-06-04 2019-05-30 4 DXCM DEXCOM INC
Common Stock
J - Other -4.052 0 -100,00
2019-05-29 2019-05-28 4 TOCA Tocagen Inc
Common Stock
P - Purchase 5.000 15.042 49,79 4,30 21.475 64.605
2019-05-17 2019-05-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -400 13.095 -2,96 122,73 -49.091 1.607.101
2019-05-17 2019-05-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -500 13.495 -3,57 121,88 -60.939 1.644.744
2019-05-17 2019-05-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -100 13.995 -0,71 118,65 -11.865 1.660.507
2019-04-19 2019-04-17 4 AMN AMN HEALTHCARE SERVICES INC
Restricted Stock Units
A - Award 2.907 2.907
2019-04-19 2019-04-17 4 AMN AMN HEALTHCARE SERVICES INC
Restricted Stock Units
M - Exercise -2.153 0 -100,00
2019-04-19 2019-04-17 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
M - Exercise 2.153 9.043 31,25
2019-04-17 2019-04-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -599 14.095 -4,08 119,36 -71.497 1.682.378
2019-04-17 2019-04-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -301 14.694 -2,01 118,88 -35.784 1.746.877
2019-04-17 2019-04-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -100 14.995 -0,66 116,96 -11.696 1.753.815
2019-03-19 2019-03-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -100 15.095 -0,66 151,97 -15.197 2.293.987
2019-03-19 2019-03-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -700 15.195 -4,40 151,00 -105.698 2.294.401
2019-03-19 2019-03-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -200 15.895 -1,24 146,92 -29.384 2.335.293
2019-03-05 2019-03-01 4 TOCA Tocagen Inc
Employee Stock Option (right to buy)
A - Award 75.000 75.000
2019-02-20 2019-02-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -200 16.095 -1,23 149,52 -29.904 2.406.524
2019-02-20 2019-02-15 4 DXCM DEXCOM INC
Common Stock
S - Sale X -800 16.295 -4,68 148,52 -118.819 2.420.195
2019-02-15 2018-06-01 5 DXCM DEXCOM INC
Common Stock
J - Other 4.952 18.095 37,68
2019-02-15 2018-06-01 5 DXCM DEXCOM INC
Common Stock
J - Other -4.952 4.052 -55,00
2018-08-28 2018-08-24 4 DXCM DEXCOM INC
Common Stock
S - Sale -1.000 17.095 -5,53 137,50 -137.503 2.350.614
2018-06-26 2018-06-01 4/A DXCM DEXCOM INC
Common Stock
A - Award 4.052 4.052 0,00 4 4
2018-06-04 2018-05-31 4 DXCM DEXCOM INC
Common Stock
A - Award 4.062 9.014 82,03 0,00 4 9
2018-04-20 2018-04-18 4 AMN AMN HEALTHCARE SERVICES INC
Restricted Stock Units
M - Exercise -3.365 0 -100,00
2018-04-20 2018-04-18 4 AMN AMN HEALTHCARE SERVICES INC
Restricted Stock Units
A - Award 2.153 0 -100,00
2018-04-20 2018-04-18 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
M - Exercise 3.365 6.890 95,46
2018-03-02 2018-03-01 4 TOCA Tocagen Inc
Employee Stock Option (right to buy)
A - Award 85.000 85.000
2017-12-14 2017-12-08 4 TOCA Tocagen Inc
Common Stock
J - Other 2.500 7.500 50,00 8,50 21.250 63.750
2017-12-06 2017-12-04 4 RGLS Regulus Therapeutics Inc.
Common Stock
A - Award 71.910 81.910 719,10 0,89 64.000 72.900
2017-11-29 2017-11-27 4 DXCM DEXCOM INC
Common Stock
S - Sale -2.500 13.143 -15,98 54,95 -137.386 722.264
2017-11-28 2017-11-27 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
S - Sale -2.500 3.525 -41,49 47,03 -117.575 165.781
2017-06-14 2017-06-13 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
S - Sale -1.500 6.025 -19,93 36,70 -55.058 221.148
2017-06-05 2017-06-01 4 DXCM DEXCOM INC
Common Stock
A - Award 4.952 20.595 31,66 0,00 5 21
2017-06-02 2017-06-01 4 RGLS Regulus Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 30.000 30.000
2017-05-31 2017-05-26 4 TOCA Tocagen Inc
Employee Stock Option (right to buy)
A - Award 85.000 85.000
2017-04-21 2017-04-19 4 TOCA Tocagen Inc
Common Stock
P - Purchase 5.000 5.000 10,00 50.000 50.000
2017-04-20 2017-04-19 4 AMN AMN HEALTHCARE SERVICES INC
Restricted Stock Units
M - Exercise -3.793 0 -100,00
2017-04-20 2017-04-19 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
M - Exercise 3.793 7.525 101,63
2017-04-20 2017-04-18 4 AMN AMN HEALTHCARE SERVICES INC
Restricted Stock Units
A - Award 3.365 3.365
2016-12-16 2016-12-15 4 AMN AMN HEALTHCARE SERVICES INC
Common Stock
S - Sale -1.800 3.732 -32,54 37,81 -68.058 141.107
2016-09-09 2016-09-07 4 DXCM DEXCOM INC
Common Stock
S - Sale -1.800 15.643 -10,32 94,62 -170.325 1.480.219
2016-06-03 2016-06-02 4 RGLS Regulus Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 36.620 36.620
2016-05-26 2016-05-25 4 DXCM DEXCOM INC
Common Stock
A - Award 5.450 17.443 45,44 0,00 5 17
2016-04-22 2016-04-20 4 AHS AMN HEALTHCARE SERVICES INC
Restricted Stock Units
A - Award 3.793 3.793
2016-04-22 2016-04-20 4 AHS AMN HEALTHCARE SERVICES INC
Restricted Stock Units
M - Exercise -5.532 0 -100,00
2016-04-22 2016-04-20 4 AHS AMN HEALTHCARE SERVICES INC
Common Stock
M - Exercise 5.532 5.532
2015-09-02 2015-08-31 4 BIOC BIOCEPT INC
Employee Stock Option (right to buy)
A - Award 50.000 50.000
2015-08-20 3 BIOC BIOCEPT INC
No securities are beneficially owned
0
2015-08-13 2015-08-13 4 RGLS Regulus Therapeutics Inc.
Common Stock
P - Purchase 10.000 10.000 7,64 76.405 76.405
2015-06-26 2015-06-10 4 RGLS Regulus Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 17.500 17.500
2015-06-05 2015-06-03 4 DXCM DEXCOM INC
Common Stock
A - Award 4.671 11.993 63,79 0,00 5 12
2015-04-24 2015-04-22 4 AHS AMN HEALTHCARE SERVICES INC
Restricted Stock Units
A - Award 5.532 5.532
2014-11-19 2014-11-17 4 DXCM DEXCOM INC
Common Stock
A - Award 6.866 7.322 1.505,70 0,00 7 7
2014-11-19 2014-11-17 4 DXCM DEXCOM INC
Common Stock
A - Award 456 456 0,00 0 0
2014-11-12 2014-11-10 4 AMBI AMBIT BIOSCIENCES CORP
Stock Option (Right to Buy)
D - Sale to Issuer -8.000 0 -100,00 8,67 -69.360
2014-11-12 2014-11-10 4 AMBI AMBIT BIOSCIENCES CORP
Stock Option (Right to Buy)
D - Sale to Issuer -14.000 0 -100,00 3,91 -54.740
2014-05-22 2014-05-22 4 "RGLS" Regulus Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 17.500 17.500
2014-05-16 2014-05-15 4 AMBI AMBIT BIOSCIENCES CORP
Stock Option (right to buy)
A - Award 8.000 8.000
2014-04-25 2014-04-23 4 AHS AMN HEALTHCARE SERVICES INC
Restricted Stock Units
A - Award 10.490 10.490
2014-01-27 2014-01-23 4 AMBI AMBIT BIOSCIENCES CORP
Stock Option (Right to Buy)
A - Award 14.000 14.000
2013-06-10 2013-06-10 4 RGLS Regulus Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 17.500 17.500
2013-04-25 2013-04-24 4 AHS AMN HEALTHCARE SERVICES INC
Restricted Stock Units
A - Award 10.015 10.015
2013-01-31 2013-01-30 4 RGLS Regulus Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 30.000 30.000
2013-01-31 3 RGLS Regulus Therapeutics Inc.
Common Stock
0
2012-12-12 2012-12-10 4 AHS AMN HEALTHCARE SERVICES INC
Restricted Stock Units
A - Award 4.092 4.092
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Performance Shares
J - Other -40.000 0 -100,00 31,00 -1.240.000
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
H - Other -46.799 0 -100,00
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
H - Other -67.289 0 -100,00
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
J - Other -65.980 0 -100,00 31,00 -2.045.380
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
J - Other -34.884 0 -100,00 31,00 -1.081.404
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
J - Other -23.722 0 -100,00 31,00 -735.382
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
J - Other -44.243 0 -100,00 31,00 -1.371.533
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
J - Other -35.475 0 -100,00 31,00 -1.099.725
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
J - Other -112.207 0 -100,00 31,00 -3.478.417
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
J - Other -70.843 0 -100,00 31,00 -2.196.133
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
J - Other -56.248 0 -100,00 31,00 -1.743.688
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
H - Other -3.201 0 -100,00
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
H - Other -2.711 0 -100,00
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
J - Other -4.020 0 -100,00 31,00 -124.620
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
J - Other -5.116 0 -100,00 31,00 -158.596
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
J - Other -8.361 0 -100,00 31,00 -259.191
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
J - Other -5.757 0 -100,00 31,00 -178.467
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
J - Other -4.525 0 -100,00 31,00 -140.275
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
J - Other -7.793 0 -100,00 31,00 -241.583
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
J - Other -9.157 0 -100,00 31,00 -283.867
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
J - Other -3.752 0 -100,00 31,00 -116.312
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
U - Other -110 0 -100,00 31,00 -3.410
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
U - Other -2.889 0 -100,00 31,00 -89.568
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
U - Other -5.085 2.889 -63,77 31,00 -157.638 89.568
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
U - Other -3.415 0 -100,00 31,00 -105.874
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
U - Other -453 3.415 -11,71 31,00 -14.040 105.874
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
J - Other -64.702 0 -100,00 31,00 -2.005.762
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
U - Other -65.115 64.702 -50,16 31,00 -2.018.565 2.005.762
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
U - Other -8.255 129.817 -5,98 31,00 -255.905 4.024.327
2012-08-10 2012-08-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
J - Other 64.702 138.072 88,19 31,00 2.005.762 4.280.232
2012-07-26 2012-07-25 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
A - Award 880 73.370 1,21 14,62 12.866 1.072.669
2012-03-07 2012-03-06 4 AMLN AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 112.207 112.207
2012-03-07 2012-03-06 4 AMLN AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
A - Award 7.793 7.793
2012-03-07 2012-03-06 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
A - Award 1.529 7.974 23,73
2012-03-07 2012-03-06 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
A - Award 10.000 72.490 16,00
2012-03-02 2012-03-01 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
S - Sale -1.846 62.490 -2,87 17,11 -31.585 1.069.204
2012-02-24 2012-02-23 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
S - Sale -5.638 63.439 -8,16 17,03 -96.016 1.080.379
2012-02-24 2012-02-22 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
A - Award 15.000 69.077 27,74
2012-02-15 2011-12-31 5 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
A - Award -488 41.699 -1,16
2012-02-10 2012-02-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
F - Taxes -3.122 54.565 -5,41 16,47 -51.419 898.686
2012-02-10 2012-02-08 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
A - Award 8.000 57.687 16,10
2012-01-12 2012-01-10 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
A - Award 7.500 49.687 17,78
2008-02-05 2008-02-01 4 AMLN AMYLIN PHARMACEUTICALS INC
Common Stock
A - Award 182 23.753 0,77 37,00 6.734 878.861
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)